Reaction
Desmoplastic Small Round Cell Tumour reporting signals
As of the last recalculation, Desmoplastic Small Round Cell Tumour appears in 87 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is TEMOZOLOMIDE (PRR 1,159.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Temozolomide | 47 | 1,159.4 | 1,162.1 |
| Pazopanib Hydrochloride | 48 | 945.4 | 947.1 |
| Ifosfamide | 41 | 862.6 | 864.2 |
| Irinotecan Hydrochloride | 21 | 514.7 | 515.5 |
| Gemcitabine | 36 | 372.3 | 372.6 |
| Gemcitabine Hydrochloride | 38 | 303.4 | 303.7 |
| Doxorubicin | 47 | 273.3 | 273.4 |
| Docetaxel Anhydrous | 37 | 227.8 | 227.9 |
| Docetaxel | 37 | 227.8 | 227.9 |
| Doxorubicin Hydrochloride | 18 | 166.0 | 166.1 |